Codupha Central Pharmaceutical JSC

Codupha Central Pharmaceutical JSC Equity Growth

The Year-over-Year Equity Growth of Codupha Central Pharmaceutical JSC (CDP.VN) as of Oct 28, 2026 is 2.98 %. In the previous year, Year-over-Year Equity Growth was 3.21 % — a change of -7.11% (lower).

Equity Growth

2.98 %

YoY

-7.11%

Last updated:

Year-over-Year Equity Growth of Codupha Central Pharmaceutical JSC is 2024 2.98 % . Year-over-Year Equity Growth of Codupha Central Pharmaceutical JSC was 2023 3.21 % . It decreases by -7.11% lower compared to the previous year.

The Codupha Central Pharmaceutical JSC Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2018
1.39 VND
Jan 1, 2019
2.40 VND
Jan 1, 2020
-1.60 VND
Jan 1, 2021
-0.00 VND
Jan 1, 2022
-2.68 VND
Jan 1, 2023
3.21 VND
Jan 1, 2024
2.98 VND
The Codupha Central Pharmaceutical JSC Equity Growth history
YEAREquity GrowthYoY
2.98 %-7.11%
3.21 %-219.54%
-2.68 %+281,683.18%
-0.00-99.94%
-1.60 %-166.46%
2.40 %+73.35%
1.39 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Codupha Central Pharmaceutical JSC Stock analysis

What does Codupha Central Pharmaceutical JSC do? Codupha Central Pharmaceutical JSC, based in Ho Chi Minh City, Vietnam, manufactures and sells pharmaceutical products. The company offers warehouse systems, delivery services, distribution centers, and import/export services. Listed on 13 July 2018, it operates primarily within Vietnam's pharmaceutical sector, providing comprehensive supply chain solutions for its products. Codupha Central Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Codupha Central Pharmaceutical JSC stock

Year-over-Year Equity Growth of Codupha Central Pharmaceutical JSC is 2.98 % in 2024.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Codupha Central Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Codupha Central Pharmaceutical JSC historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — Codupha Central Pharmaceutical JSC

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — Codupha Central Pharmaceutical JSC